跳转至内容
Merck
CN
  • Whole-body phenylalanine kinetics and skeletal muscle protein signaling in horses with pituitary pars intermedia dysfunction.

Whole-body phenylalanine kinetics and skeletal muscle protein signaling in horses with pituitary pars intermedia dysfunction.

American journal of veterinary research (2014-06-25)
Laurel M Mastro, Amanda A Adams, Kristine L Urschel
摘要

To compare whole-body phenylalanine kinetics and the abundance of factors in signaling pathways associated with skeletal muscle protein synthesis and protein breakdown between horses with pituitary pars intermedia dysfunction (PPID) and age-matched control horses without PPID. 12 aged horses (6 horses with PPID and 6 control horses; mean age, 25.0 and 25.7 years, respectively). Plasma glucose, insulin, and amino acids concentrations were determined before and 90 minutes after feeding. Gluteal muscle biopsy samples were obtained from horses 90 minutes after feeding, and the abundance and activation of factors involved in signaling pathways of muscle protein synthesis and breakdown were determined. The next day, horses received a priming dose and 2 hours of a constant rate infusion of (13)C sodium bicarbonate followed by a priming dose and 4 hours of a constant rate infusion of 1-(13)C phenylalanine IV; whole-body protein synthesis was determined. Plasma glucose and insulin concentrations were higher after feeding than they were before feeding for both groups of horses; however, no significant postprandial increase in plasma amino acids concentrations was detected for either group. Phenylalanine flux, oxidation, release from protein breakdown, and nonoxidative disposal were not significantly different between groups. No significant effect of PPID status was detected on the abundance or activation of positive or negative regulators of protein synthesis or positive regulators of protein breakdown. Results of this study suggested that whole-body phenylalanine kinetics and the postprandial activation of signaling pathways that regulate protein synthesis and breakdown in muscles were not affected by PPID status alone in aged horses.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
碳酸氢钠, ACS reagent, ≥99.7%
Sigma-Aldrich
碳酸氢钠, powder, BioReagent, Molecular Biology, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
碳酸氢钠, ReagentPlus®, ≥99.5%, powder
Sigma-Aldrich
L -异亮氨酸, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
碳酸氢钠, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99.7%
Sigma-Aldrich
碳酸氢钠, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E500, 99.0-100.5%, powder
Sigma-Aldrich
L-苏氨酸, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 99.0-101.0%
Sigma-Aldrich
L-苯基丙氨酸, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L -异亮氨酸, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
L-苏氨酸, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
L-苯基丙氨酸, reagent grade, ≥98%
Sigma-Aldrich
碳酸氢钠, BioXtra, 99.5-100.5%
USP
碳酸氢钠, United States Pharmacopeia (USP) Reference Standard
SAFC
L-苏氨酸
SAFC
L -异亮氨酸
Sigma-Aldrich
L-苯基丙氨酸, BioUltra, ≥99.0% (NT)
USP
L-苯基丙氨酸, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
L -异亮氨酸, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
DL-苯丙氨酸, ReagentPlus®, 99%
Supelco
L-苯基丙氨酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
DL -色氨酸, ≥99% (HPLC)
Sigma-Aldrich
L-苏氨酸, BioXtra, ≥99.5% (NT)
Sigma-Aldrich
碳酸氢钠, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99.5%
Supelco
L -异亮氨酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
DL -色氨酸, ≥99% (HPLC)
组氨酸, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
碳酸氢钠, −40-+140 mesh, ≥95%
Sigma-Aldrich
碳酸氢钠, tested according to Ph. Eur.
Supelco
L-苏氨酸, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
DL-缬氨酸, ReagentPlus®, ≥99.0% (NT)